DnB Asset Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
DnB Asset Management's VKTX Position: Q3 2026 in Review
DnB Asset Management increased its Viking Therapeutics (VKTX) stake by 73% in Q3 2026, buying an estimated $505K and bringing the position to 34,509 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #630.
DnB Asset Management first reported a position in VKTX in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.23M in Q4 2024. 444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- DnB Asset Management held 34,509 shares of Viking Therapeutics worth $1.12M as of Q3 2026.
- DnB Asset Management bought 14,567 Viking Therapeutics shares in Q3 2026, an estimated $505K.
- Viking Therapeutics made up ﹤0.01% of DnB Asset Management's portfolio in Q3 2026, its #630 holding.
- DnB Asset Management first reported a position in Viking Therapeutics in Q1 2024 and has held it in 11 quarters since.
- DnB Asset Management's Viking Therapeutics position peaked at $1.23M in Q4 2024.
- 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on DnB Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.